These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17897082)

  • 1. Novel phospholipase-resistant lipid/peptide synthetic lung surfactants.
    Notter RH; Schwan AL; Wang Z; Waring AJ
    Mini Rev Med Chem; 2007 Sep; 7(9):932-44. PubMed ID: 17897082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids.
    Notter RH; Gupta R; Schwan AL; Wang Z; Shkoor MG; Walther FJ
    PeerJ; 2016; 4():e2635. PubMed ID: 27812430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants.
    Revak SD; Merritt TA; Hallman M; Heldt G; La Polla RJ; Hoey K; Houghten RA; Cochrane CG
    Pediatr Res; 1991 May; 29(5):460-5. PubMed ID: 1896249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic surface activity of a fully synthetic phospholipase-resistant lipid/peptide lung surfactant.
    Walther FJ; Waring AJ; Hernandez-Juviel JM; Gordon LM; Schwan AL; Jung CL; Chang Y; Wang Z; Notter RH
    PLoS One; 2007 Oct; 2(10):e1039. PubMed ID: 17940603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic amphipathic sequences of surfactant protein-B mimic several physicochemical and in vivo properties of native pulmonary surfactant proteins.
    Waring A; Taeusch W; Bruni R; Amirkhanian J; Fan B; Stevens R; Young J
    Pept Res; 1989; 2(5):308-13. PubMed ID: 2562485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mixtures of surfactant lipids and synthetic sequences of surfactant proteins SP-B and SP-C.
    Amirkhanian JD; Bruni R; Waring AJ; Taeusch HW
    Biochim Biophys Acta; 1991 Jun; 1096(4):355-60. PubMed ID: 2065107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of model human pulmonary surfactants with a mixed phospholipid bilayer assembly: Raman spectroscopic studies.
    Vincent JS; Revak SD; Cochrane CD; Levin IW
    Biochemistry; 1993 Aug; 32(32):8228-38. PubMed ID: 8347622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.
    Wang Z; Chang Y; Schwan AL; Notter RH
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical and biological activity of a synthetic 8.7-kDa hydrophobic pulmonary surfactant protein SP-B.
    Sarin VK; Gupta S; Leung TK; Taylor VE; Ohning BL; Whitsett JA; Fox JL
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2633-7. PubMed ID: 2320580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant protein B: lipid interactions of synthetic peptides representing the amino-terminal amphipathic domain.
    Bruni R; Taeusch HW; Waring AJ
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7451-5. PubMed ID: 1871144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic pulmonary surfactant preparations: new developments and future trends.
    Mingarro I; Lukovic D; Vilar M; Pérez-Gil J
    Curr Med Chem; 2008; 15(4):393-403. PubMed ID: 18288994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
    Notter RH; Shapiro DL; Ohning B; Whitsett JA
    Chem Phys Lipids; 1987 Jun; 44(1):1-17. PubMed ID: 3607971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixtures of synthetic peptides and dipalmitoylphosphatidylcholine as lung surfactants.
    McLean LR; Krstenansky JL; Jackson RL; Hagaman KA; Olsen KA; Lewis JE
    Am J Physiol; 1992 Mar; 262(3 Pt 1):L292-300. PubMed ID: 1550252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The surface properties of chemically synthesized peptides analogous to human pulmonary surfactant protein SP-C.
    Takei T; Hashimoto Y; Aiba T; Sakai K; Fujiwara T
    Biol Pharm Bull; 1996 Oct; 19(10):1247-53. PubMed ID: 8913491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein composition of synthetic surfactant affects gas exchange in surfactant-deficient rats.
    Walther FJ; Hernández-Juviel J; Bruni R; Waring AJ
    Pediatr Res; 1998 May; 43(5):666-73. PubMed ID: 9585014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo function of surfactants containing phosphatidylcholine analogs.
    Dizon-Co L; Ikegami M; Ueda T; Jobe AH; Lin WH; Turcotte JG; Notter RH; Rider ED
    Am J Respir Crit Care Med; 1994 Oct; 150(4):918-23. PubMed ID: 7921463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic mimics of surfactant proteins B and C: in vitro surface activity and effects on lung compliance in two animal models of surfactant deficiency.
    Bruni R; Hernández-Juviel JM; Tanoviceanu R; Walther FJ
    Mol Genet Metab; 1998 Feb; 63(2):116-25. PubMed ID: 9562965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary structure and lipid interactions of the N-terminal segment of pulmonary surfactant SP-C in Langmuir films: IR reflection-absorption spectroscopy and surface pressure studies.
    Bi X; Flach CR; Pérez-Gil J; Plasencia I; Andreu D; Oliveira E; Mendelsohn R
    Biochemistry; 2002 Jul; 41(26):8385-95. PubMed ID: 12081487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic pulmonary surfactants.
    McLean LR; Lewis JE
    Life Sci; 1995; 56(6):363-78. PubMed ID: 7830498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface properties of sulfur- and ether-linked phosphonolipids with and without purified hydrophobic lung surfactant proteins.
    Chang Y; Wang Z; Schwan AL; Wang Z; Holm BA; Baatz JE; Notter RH
    Chem Phys Lipids; 2005 Oct; 137(1-2):77-93. PubMed ID: 16109391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.